The short answer
Losing 5% to 10% of your body weight usually lowers blood pressure, blood sugar and triglycerides and improves cholesterol to a smaller degree, and the benefit grows as more weight comes off [4][6]. What a large randomised lifestyle trial did not show is a clear drop in heart attacks and strokes from diet-and-activity weight loss alone [2]. The only randomised proof of fewer heart events comes from a semaglutide trial in adults who already had heart disease [1].
The bottom line: treat weight loss as a strong way to improve your risk factors, and judge any promise of fewer heart attacks by who was actually studied. Four things need to be kept apart: • Risk-factor change: measured over weeks to months, with strong support [4][6]. • Heart events in lifestyle trials: no clear difference in a large randomised trial [2]. • Observational and surgery cohorts: fewer events, but not randomised [3][5]. • Medicine outcome trial: fewer events, only in people with established heart disease [1][8].
Losing 5% to 10%: what happens to blood pressure, sugar and lipids
If you weigh 100 kg, a 5% loss is 5 kg and a 10% loss is 10 kg. These are the figures the sources report: • Blood pressure: the 2013 AHA/ACC/TOS guideline review found that at a 5% loss the average fall was about 3 mmHg in systolic and 2 mmHg in diastolic pressure, with smaller and more variable falls below 5% [6]. • Triglycerides and sugar: the same guideline says a sustained 3% to 5% loss is likely to give clinically meaningful reductions in triglycerides, blood glucose, HbA1c and the risk of developing type 2 diabetes [6]. • Cholesterol: it says improving LDL and HDL cholesterol needs a greater loss, which also reduces the need for medicines for blood pressure, sugar and lipids [6]. • Sugar in type 2 diabetes: a 5% to 10% loss is linked to HbA1c reductions of 0.6 to 1.0 percentage points [6].
These are averages. Your own numbers may move more or less, which is why we measure before and after instead of promising a particular result.
Numbers from people followed for a full year
An analysis published in Diabetes Care followed 5,145 people with type 2 diabetes and overweight for a year, and compared those who lost 5% to under 10% (about 7.25 kg on average) with those whose weight stayed stable [4]. The result is reported as odds, meaning the chance of reaching an improvement compared with the stable group, not a guarantee: • HbA1c falling by at least 0.5 points: odds 3.52 times higher. • Systolic pressure falling by at least 5 mmHg: odds 1.56 times higher. • Diastolic pressure falling by at least 5 mmHg: odds 1.48 times higher. • HDL cholesterol rising by at least 5 mg/dL: odds 1.69 times higher. • Triglycerides falling by at least 40 mg/dL: odds 2.20 times higher. Notably, LDL cholesterol did not change with weight loss in this analysis [4]. The odds were higher still at a 10% to 15% loss for most risk factors [4].
One caution: all participants had type 2 diabetes, so these figures are not necessarily the same for someone without diabetes.
When the loss is larger than 10%
The more weight comes off, the more the risk factors improve. In a randomised trial of 2,539 adults with obesity, or overweight plus a weight-related complication, without diabetes, followed for 72 weeks on tirzepatide, the average loss was 15.0%, 19.5% and 20.9% depending on the dose, against 3.1% on placebo [7]. A loss of 5% or more was reached by 85%, 89% and 91% of people, against 35% [7]. The researchers reported improvement in all prespecified cardiometabolic measures [7].
The limit matters here: this trial measured weight and risk factors, not heart attacks and strokes [7]. So we can say the medicine lowers weight substantially and improves the markers, but we cannot take event reductions from it. If you are thinking about medicines, read who can take weight-loss injections, and the decision is made with your doctor.
Better numbers do not always mean fewer heart events: the lifestyle trial
A large randomised trial that tested this question enrolled 5,145 people with type 2 diabetes and overweight or obesity. One group got an intensive lifestyle programme and the other got usual support and education [2]. The intensive group lost 8.6% of its weight in the first year against 0.7%, and by the end of the study the gap was 6.0% against 3.5% [2]. Their HbA1c, fitness and most risk factors improved, except LDL cholesterol [2].
But the trial was stopped at a median of 9.6 years because it was unlikely to reach a difference in the main outcome. The combined events (cardiovascular death, heart attack, stroke, or hospital admission for angina) numbered 403 in the intensive group against 418 in the other, which is 1.83 against 1.92 per 100 person-years, with a hazard ratio of 0.95 and a confidence interval of 0.83 to 1.09 [2]. That difference is not statistically clear.
In plain language: improving the numbers is useful and worthwhile, but in people with type 2 diabetes, an average loss of about 6% through lifestyle alone did not show a clear drop in heart events in this study [2]. That is not a reason to ignore weight. It is a reason to stay realistic.
An encouraging signal that is not proof: those who lost 10% in year one
The same trial was analysed again later from a different angle: instead of comparing the two groups, researchers compared people by what happened to each person's own weight [3]. Among 4,834 people followed for a median of 10.2 years, those who lost 10% or more in the first year had a hazard ratio of 0.79 for the primary outcome (confidence interval 0.64 to 0.98) compared with those whose weight stayed stable or rose [3]. For the secondary outcome it was 0.76 [3].
So larger loss went with fewer events. But we have to separate the two ideas: this is an observational, post-hoc analysis, so it shows an association, not a direct cause [3]. People who lose 10% may already be more consistent with medicines, follow-up and activity, and that affects the result. Read the number as a signal worth following, not as a promise.
Large, sustained loss: the bariatric surgery cohort
Long-term data on large weight loss come from a Swedish study that followed people who had bariatric surgery. It compared 2,010 people who had surgery with 2,037 matched people who received usual care, with a median follow-up of 14.7 years [5]. Cardiovascular deaths numbered 28 against 49 (adjusted hazard ratio 0.47), and first heart attack or stroke numbered 199 against 234 events (adjusted hazard ratio 0.67) [5].
We have to say clearly that this study was not randomised, so the people who chose surgery may differ from those who did not [5]. Our clinic does not offer surgery either, so the reason to mention it is to show that a large, sustained loss was associated with fewer events over many years, not to recommend a particular route. What matters most in practice is staying with it, because the benefit is built over years, not weeks.
The one randomised proof of fewer events: the semaglutide trial
This trial (SELECT) was published in the New England Journal of Medicine in 2023 and enrolled 17,604 adults aged 45 or older with established cardiovascular disease and a BMI of 27 or more, without diabetes [1]. They received semaglutide 2.4 mg weekly (8,803 people) or placebo (8,801 people), with a mean follow-up of 39.8 months [1]. The main outcome (cardiovascular death, non-fatal heart attack or non-fatal stroke) occurred in 6.5% against 8.0%, a hazard ratio of 0.80 (confidence interval 0.72 to 0.90) [1].
That fits the licensing: the US FDA-approved Wegovy label lists the medicine to reduce the risk of major adverse cardiovascular events in adults with established cardiovascular disease and either obesity or overweight, together with a reduced-calorie diet and more activity [8].
Three limits to keep in mind. First, participants already had heart disease, so the result does not automatically transfer to someone without it [1]. Second, the trial tested a medicine, so we cannot say how much of the benefit came from weight loss itself. Third, 16.6% of those on the medicine permanently stopped it because of adverse events, against 8.2% on placebo [1].
How to check that weight loss is helping your heart
The figures in studies are averages, so it is better to know your own numbers before you start and again after a few months. What we suggest recording: • Blood pressure: in clinic and at home. High blood pressure can lead to heart attacks and strokes and usually has no symptoms, so measuring is the only way to know it [11]. • Waist and weight: measured at each visit. Living with overweight raises the risk of heart disease, stroke and high blood pressure [10]. The WHO links obesity to a rising burden of diabetes and cardiovascular disease [9]. • Blood tests: fasting sugar and HbA1c, and blood fats (cholesterol and triglycerides), compared before and some time after weight loss, as your doctor decides. • Body composition on an InBody device, to follow fat and muscle so that the loss is not coming from muscle.
If you take medicines for blood pressure, sugar or cholesterol, the doctor who prescribed them is the one who reviews doses as your numbers change, and you should not change them yourself. For details, read our plan for weight loss with high blood pressure and how blood pressure medicines are reviewed as weight falls.
Who needs a closer heart-risk review alongside weight loss
Weight loss helps almost everyone, and obesity raises the risk of heart disease, stroke and high blood pressure [10], but some people have a higher heart risk, so we review the whole picture with them: • Rheumatoid arthritis: we review the full picture of risk factors alongside rheumatoid treatment. Read our review of heart risk in rheumatoid arthritis. • High cholesterol results: weight loss is part of the plan, but any decision about medicines is taken after reading the full blood results. Read high cholesterol results and next steps. • Diabetes, high blood pressure or a family history of early heart disease: we follow the numbers with them at closer intervals. • Known heart disease: weight loss is done under your own doctor's supervision, and any talk of weight medicines is discussed with them.
Our clinic has internal medicine, weight management, nutrition and rheumatology. We do not have a cardiology department, so heart-risk review here is done as part of internal medicine and weight management in Maadi, and if you need a specialist heart assessment we direct you to one.
Symptoms that cannot wait for a clinic: get emergency help now
Weight loss lowers risk factors, but it does not remove the chance of a heart attack. If any of these appear, do not wait for a clinic appointment and do not try to fix it with weight loss: • Chest pain that feels like pressure, squeezing or tightness, which may spread to the arm, neck or jaw [12]. • Shortness of breath [12]. • Nausea, vomiting, or feeling like you have indigestion with sweating [12]. • Pale, blue or grey skin [12]. • Fainting, severe difficulty breathing, or being unable to get words out [12].
The right action: call an ambulance on 123 in Egypt or go to the nearest emergency room straight away. Do not drive yourself if you have chest pain. And do not wait, because a heart attack needs emergency treatment in hospital [12].
To be clear: our clinic is not an emergency department and has no cardiology, so symptoms like these belong in the emergency room, not in a booking. Booking here is for an organised review of risk factors and a weight plan once your condition is stable.
When to book a weight and heart-risk review
Book a visit if: • You want to lose weight and have raised blood pressure, sugar, cholesterol or triglycerides [6][11]. • You have a family history of early heart disease or rheumatoid arthritis and want to know your own risk numbers. • You have started losing weight and want to track your numbers before and after instead of guessing [4][6]. • You take long-term medicines and want a weight plan that works with them, while the doctor who prescribed them is the one who changes doses.
The review is done in internal medicine and weight management (Dr Mohab Ashraf Fouad in Maadi) and includes a blood pressure check, body composition on an InBody device and a decision on which blood tests are needed. Branches: Maadi (14 El-Mokhtar Street, behind QNB, New Maadi) and Fifth Settlement (CMC Medical Mall, 4th floor, North 90th Street, Wednesdays from 3:30 pm) for weight management, nutrition and rheumatology. When you are ready, book your appointment from the link below.
Read also: Book an appointment
